Purchase Order 75N91022P00328
Award Date 3/21/22
Potential Completion Date 3/20/27
Potential Value $300K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI), an agency within the Department of Health and Human Services, awarded a $76,500 firm fixed price purchase order to Cancer Letter Inc. to provide an annual institution-wide online subscription to cancer research and drug development content through The Cancer Letter publication. The contract covers a 12-month period from September 21, 2018 to September 20, 2019, with access for 3,000-4,000 users. The subscription includes weekly updates on cancer-related...
- The National Cancer Institute awarded a purchase order to Cancer Letter Inc. for an institutional subscription to The Cancer Letter, valued at $250,000, on June 16, 2026. The procurement, conducted as a simplified acquisition under FAR Part 13, was awarded without full and open competition on a brand-name basis. Performance occurs in Washington, DC. The subscription provides NCI staff access to The Cancer Letter's weekly online publication covering cancer research, drug development, and health...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $120,000 firm fixed price purchase order to Cancer Letter Inc., doing business as The Cancer Letter, for an annual institution-wide online subscription to cancer research and drug development content. The subscription provides access for 3,000-4,000 users, with 24/7 access to current and archived cancer-related news, summaries of NCI and FDA grant opportunities and drug approvals, cancer...
- Springer Nature Customer Service Center LLC has been awarded an $11,690 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to provide manuscript publication services. The firm fixed price contract runs from June 2023 through June 2024 and will be performed in Bowling Green, New York. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $11,690 firm fixed price purchase order to Springer Nature Customer Service Center LLC. Under this contract, Springer Nature will publish a scientific manuscript submitted to the journal Nature Cancer. The manuscript, titled "MANUSCRIPT: #NATCANCERA05718B," was reviewed and accepted for publication based on its relevance to the unique focus of the journal. Performance will take...
- <p>The National Cancer Institute issued a delivery order to Palladian Partners, Inc. on February 27, 2018, for branding of a new epidemiological study of cancer, with a ceiling value of $69,915.17.</p> <p>The order was issued under the NIH Public Information and Communication 2012–2016 indefinite-delivery contract. Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of May 31, 2019.</p>
- This federal contract award, valued at $17,185.00, was issued by the National Cancer Institute (NCI) to the Public Library of Science (PLOS) to coordinate the submission, peer review, production, and promotion of a collection of 10 articles on cancer systems epidemiology insights and future opportunities. The contract is a firm fixed-price purchase order with a period of performance from September 1, 2020 to August 31, 2022. PLOS, a non-profit organization, will be responsible for managing the...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract is for the production of a supplement to the Journal of the National Cancer Institute (JNCI) Monographs, specifically a 50th anniversary issue of the NCI's Surveillance, Epidemiology, and End Results (SEER) Program. The contract has a ceiling value of $77,580.00 and a...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
- The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...
The National Cancer Institute, an agency of the Department of Health and Human Services, awarded a firm fixed price purchase order to Cancer Letter Inc. for an annual institution-wide subscription to The Cancer Letter publication. The $300,000 contract has a base period of performance from March 21, 2022 to March 20, 2023, with options to extend the subscription through March 20, 2027. The Cancer Letter is a weekly online publication covering cancer research, drug development, and health policy. Cancer Letter Inc. has previously provided subscriptions to the National Cancer Institute through similar prime contract awards. No set-aside designation was used for this contract.
Generated 3/25/25, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $50.0k | 3/24/25 | |
| P00002 | Exercise an Option | $50.0k | 1/22/24 | |
| P00001 | Exercise an Option | $50.0k | 3/17/23 | |
| Not listed | Not listed | $50.0k | 3/17/22 |